1 The U.S. Preventive Services Task Force: The Challenge of Transparency Dr. Albert Siu New York Academy of Medicine.

Slides:



Advertisements
Similar presentations
CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.
Advertisements

1 Understanding How the U.S. Preventive Services Task Force Works USPSTF 101.
Participation Requirements for a Guideline Panel Member.
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Participation Requirements for a Guideline Panel Co-Chair.
Participation Requirements for a Patient Representative.
Clinical Alliances and Partnerships Raul A. Romaguera, DMD, MPH Division of HIV/AIDS Prevention Centers for Disease Control and Prevention March 11, 2004.
Medical Library & Peyton T. Anderson Learning Resources Center Macon, GA Memorial University Medical Center Health Sciences.
Mary Barton, MD, MPP Vice President, Performance Measures “Balancing scientific and social dimensions of guidelines”
Decision Criteria and Process Advisory Committee on Heritable Disorders in Newborns and Children February 26-27, 2009.
Improving The Clinical Care of Children and Adolescents With Mild Traumatic Brain Injury Madeline Joseph, MD, FACEP, FAAP Professor of Emergency Medicine.
Participation Requirements for a Guideline Panel PGIN Representative.
Knowing What Works in Health Care : A Roadmap for the Nation Alliance for Health Reform April 4, 2008 Wilhelmine Miller, MS, PhD GWU SPHHS.
UPenn Prevention Research Center’s CPCRN Collaborating Center University of Pennsylvania (UPenn) Prevention Research Center is a new PRC, Principal.
Developed through the APTR Initiative to Enhance Prevention and Population Health Education in collaboration with the Brody School of Medicine at East.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care US Preventive Services Task Force Kenneth Lin, MD, Medical.
Accessing Sources Of Evidence For Practice Introduction To Databases Karen Smith Department of Health Sciences University of York.
Tobacco Cessation and Private Insurance under ACA: New Opportunities for Public Health September 25, 2014.
Systematic Reviews and the American Academy of Pediatrics Virginia A. Moyer, MD, MPH Professor of Pediatrics Baylor College of Medicine.
Chapter 7. Getting Closer: Grading the Literature and Evaluating the Strength of the Evidence.
Topic Generation and Research Prioritization Joe V. Selby, MD, MPH, Executive Director Rachael Fleurence, PhD, Scientist Rick Kuntz, MD, MSc, Chair, PDC.
Critical Appraisal of Clinical Practice Guidelines
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Report to Los Angeles County Executive Office And Los Angeles County Health Services Agencies Summary of Key Questions for Stakeholders February 25, 2015.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
Patients at the Center: Guidelines for Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality New York Academy of Medicine.
Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators.
U.S. Department of Agriculture Center for Nutrition Policy and Promotion Slides provided by the USDA Center for Nutrition Policy and Promotion.
1 Copyright © 2011 by Saunders, an imprint of Elsevier Inc. Chapter 13 Building an Evidence-Based Nursing Practice.
Revision Process for the PHS Guideline for Reducing HIV, HBV and HCV Transmission through Solid Organ Transplantation Matthew J. Kuehnert, M.D. Office.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
The Affordable Care Act (ACA) and Public Health Nate Smith, MD, MPH Director and State Health Officer Arkansas Department of Health.
Evidence Review Group: Past to Present James M. Perrin, MD Professor of Pediatrics, Harvard Medical School MGH Center for Child and Adolescent Health Policy.
Finding Relevant Evidence
HW215: Models of Health & Wellness Unit 7: Health and Wellness Models Geo-political Influences.
Deciding how much confidence to place in a systematic review What do we mean by confidence in a systematic review and in an estimate of effect? How should.
Put Prevention Into Practice. Understand the PPIP Program What is Put Prevention Into Practice (PPIP)? What is Put Prevention Into Practice (PPIP)? Why.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
1 Health Care Reform-- Report Back from CDC Consultation on 10/7/10 James Watt October 19, 2010.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Reimbursement: A Look Inside the Black Box Eric L. Book, MD March 27,
Appraisal of Guidelines for Research & Evaluation Using the AGREE¹ Instrument CAN-IMPLEMENT Toolkit Version 1.0 April 2010 Modified from:
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
11 The CPCRN, DCPC, NCI, and the Community Guide: Areas for Collaboration and Supportive Work Shawna L. Mercer, MSc, PhD Director The Guide to Community.
Moving the Evidence Review Process Forward Alex R. Kemper, MD, MPH, MS September 22, 2011.
Recommendation Methods Advisory Committee on Heritable Disorders and Genetic Diseases of Newborns and Children Ned Calonge, M.D., M.P.H.
USPSTF CLINICAL GUIDELINES IN A PHYSICIAN ASSISTANT CURRICULUM Timothy Quigley, MPH, PA-C Associate Professor Wichita State University.
Implementing the GRADE Method in Guideline Development: Real- World Experiences Contemplation Stage: To GRADE or Not to GRADE? Sheila A. Agyeman, MHA Director.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Understanding the Methods Used by the U.S. Preventive Services.
Developing evidence-based guidelines at WHO. Evidence-based guidelines at WHO | January 17, |2 |
EHealth Initiative Business and Clinical Motivator Work Group January 21, :00 p.m. EDT.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
The ACA and Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) Implications for Tobacco Cessation Therapies Steve Melek, FSA, MAAA February.
Developing Practice Guidelines for the U.S. Preventive Services Task Force: A Hands-On Approach Kenneth Lin, MD Medical Officer, AHRQ STFM Annual Spring.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Building an Evidence-Based Nursing Practice
Developing a guideline
US Preventive Services Task Force :
Kenneth Lin, MD, FAAFP STFM NE Region Meeting November 1, 2008
WHO Guideline development
The Affordable Care Act (ACA) and Public Health
Component 1: Introduction to Health Care and Public Health in the U.S.
EUnetHTA Assembly May 2018.
From the Evidence Analysis to the Creation of Evidence Based Guidelines 1.
Presentation transcript:

1 The U.S. Preventive Services Task Force: The Challenge of Transparency Dr. Albert Siu New York Academy of Medicine

2 Background The U.S. Preventive Services Task Force… Established in 1984 Makes recommendations on clinical preventive services for primary care The USPSTF scope for clinical preventive services includes: screening tests counseling services preventive medications Services offered in a primary care setting or referable from primary care Applicable to adults & children with no signs or symptoms Recommendations based on a rigorous analysis of peer-reviewed evidence

3 Who is the USPSTF? Experts in primary care, prevention, research methods Congressionally mandated and government supported, by AHRQ, but independent Represent family medicine, internal medicine, pediatrics, obstetrics/gynecology, nursing, behavioral medicine Scientific support from Evidence-based Practice Centers (EPCs) Non-member liaisons (“Partners”) from primary care clinician associations, Federal agencies

4 Topic Selection & Prioritization Anyone can nominate a topic for the USPSTF to consider via its Web site Nominated topics are prioritized to balance the overall portfolio of recommendations by populations, types of services (screening, counseling, preventive medications), and disease types Scope (i.e., asymptomatic population, primary care setting) Health burden Expected effectiveness of the preventive service to reduce that burden Potential for a Task Force recommendation to affect clinical practice (based on existing controversy or the belief that a gap exists between evidence and practice)

5 Steps the USPSTF Takes to Solicit Public Input and Make a Recommendation

6 Steps the USPSTF Takes to Solicit Public Input and Make a Recommendation: Step 1

7 Analytic Framework for Lung Cancer Screening

8 Analytic Framework for Hepatitis C Screening

9 Steps the USPSTF Takes to Solicit Public Input and Make a Recommendation: Step 2

10 Evidence Review: Define & Retrieve Relevant Evidence For each Key Question developed from Analytic Framework: Create inclusion/exclusion criteria based on the key questions defined from the analytic framework PubMed, Cochrane, and Other database search (CINAHL, etc.) References from key articles, editorials, review articles Expert consultation (others, TF members)

11 Steps the USPSTF Takes to Solicit Public Input and Make a Recommendation: Step 3

12 Synthesize & Judge Overall Strength of Evidence Convincing: Well-designed, well-conducted studies in representative populations that directly assess effects on health outcomes Adequate: Sufficient to determine effects on health outcomes, but limited by number, quality, or consistency of studies, generalizability to routine practice, or indirect nature of the evidence Inadequate: Insufficient due to limited number or power of studies, important flaws in their design or conduct, gaps in the chain of evidence, or lack of information on important health outcomes

13 Assessment of Net Benefit & Recommendation Likelihood that the assessment of the net benefit of a preventive service is correct Net benefit is defined as benefit minus harm of the preventive service as implemented in a primary care population The USPSTF assigns a certainty level based on the nature of the overall evidence available to assess the net benefit of a preventive service

14 Level of Certainty High Certainty: The available evidence usually includes consistent results from well-designed, well-conducted studies in representative primary care populations, using health outcomes. This conclusion is therefore unlikely to be strongly affected by the results of future studies. Moderate Certainty: The available evidence is sufficient to determine the effects of the preventive service on health outcomes, but confidence in the estimate is constrained by limitations in the research. As more information becomes available, the magnitude or direction of the observed effect could change, and this change may be large enough to alter the conclusion. Low Certainty: The available evidence is insufficient to assess effects on health outcomes.

15 Grade Recommendations Certainty of Net BenefitMagnitude of Net Benefit SubstantialModerateSmallZero/negative HighABCD ModerateBBCD Low Insufficient (I Statement)

16 Patient Protection and Affordable Care Act: Investment in prevention… A group health plan and a health insurance issuer offering group or individual health insurance coverage shall provide coverage for and shall not impose any cost sharing requirements for Evidence-based items or services that have … a rating of ‘A’ or ‘B’ in the current recommendations of the United States Preventive Services Task Force

17 Steps the USPSTF Takes to Solicit Public Input and Make a Recommendation: Step 4

18 External Review of Draft Recommendation Statement Consideration of Public Comment & Revision of Draft Recommendation Statement — Ratification of Final Recommendation Statement Publication of Final Recommendation Statement Draft Evidence Report External Review of Draft Evidence Report by Experts USPSTF Topic Workgroup Reviews Evidence & Prepares Preliminary Recommendation Full USPSTF Reviews Evidence & Debates Preliminary Recommendation Topic Workgroup Prepares Full Draft Recommendation Statement Final Evidence Report & Manuscript Published External Review of Draft Research Plan Approval of External-reviewed Final Research Plan Opportunities for Public Input Engagement Opportunity for Public Comment Topic Nomination Topic Selection Draft Research Plan Development Opportunity for Public Comment FUTURE Opportunity for Public Comment

19 Important Considerations for Success The commitment to evidence is what makes the USPSTF recommendations the “gold standard” for clinical preventive services Recommendations are used for national performance measures and policy Public-private partnership is valuable model The USPSTF is an INDEPENDENT entity, but our work is made possible through the partnership with AHRQ AHRQ convenes the USPSTF and provides scientific, technical, administrative, and dissemination support

20 Important Considerations for Success Rigorous, systematic and TRANSPARENT processes USPSTF Procedure Manual is available online Explicit conflict of interest procedures Analytic frameworks, draft reports, and draft recommendation statements are available for public comment Expanded dissemination (plain language fact sheets) Efforts to engage the media Engaging stakeholders in the process through briefings and other activities

21 Public Input on Hepatitis C Screening – 11/28/12 “Advocates for wider screening for hepatitis C criticized a government panel Tuesday for not issuing a stronger recommendation that all baby boomers get a test to make sure they aren’t infected with the deadly virus. The National Viral Hepatitis Roundtable, a coalition of groups that battle viral hepatitis, said that the task force recommendation doesn’t match up with Centers for Disease Control guidelines that everyone born between 1945 and 1965 be tested. “We’ll miss a tremendous opportunity to save lives,” said the executive director of the group.” “I'd still argue that the magnitude of benefit is less than either the CDC or Task Force say it is... there's no direct evidence that screening for hepatitis C saves lives. New treatments are more likely to lead to SVR, but there's no evidence that they save lives.”

22 Benefits and “Harms” of Public Engagement Benefits Corrections to analytic framework Improved wording of recommendation statement Changed recommendation grade based on new evidence Better articulated critical evidence gaps “Harms” Longer timeline Additional resources More time from task force “volunteers” in activities outside of comfort zone

23 Thank you for your interest

24